SwineMate® (altrenogest)

SwineMate® (altrenogest) is indicated for synchronization of estrus in sexually mature gilts that have had at least one estrous cycle. Treatment with SwineMate® results in estrus (standing heat) 4 to 9 days after completion of the 14-day treatment period.

Product Features

Manufactured in an FDA-approved facility
Dosage – 6.8 mL/day for 14 consecutive days (15 mg of altrenogest per day)
Achieve standing heat 4-9 days after SwineMate® treatment
The cost-effective alternative to MATRIX®
The same active ingredient as MATRIX®
Operating efficiency improved by controlling estrus synchronization
Predictable breeding time table for sexually mature gilts that have had at least one estrus
SwineMate® is used to synchronize the estrous cycle of gilts

Package presentation	Available
1000 mL Bottle	Reorder No: 22000

Clicking a link on this page will open a PDF file in a new window.

MATRIX is a Registered Trademark of Merck Animal Health

INDICATIONS:

For synchronization of estrus in sexually mature gilts that have had at least one estrous cycle. Treatment with SwineMate® results in estrus (standing heat) 4 to 9 days after completion of the 14-day treatment period.

DOSAGE AND ADMINISTRATION:

Administer 6.8 mL (15 mg altrenogest) per gilt once daily for 14 consecutive days. Treat gilts on an individual animal basis by top-dressing SwineMate® on a portion of each gilt’s daily feed allowance. To produce the desired synchronization of estrus in a group of gilts, treat all of the gilts daily for the same 14-day period.

IMPORTANT SAFETY INFORMATION:

SwineMate® is contraindicated for use in gilts having a previous or current history of uterine inflammation (i.e., acute, subacute or chronic endometritis). Underdosing of SwineMate® may lead to the occurrence of cystic follicles. Gilts intended for human consumption must not be slaughtered within 21 days of the last treatment with this drug product. Avoid skin contact. SwineMate® is absorbed through unbroken skin, and exposure may result in serious side effects to both women and men. Wear vinyl, neoprene, or nitrile gloves when handling or administering SwineMate®, or when touching contaminated surfaces or equipment. DO NOT USE LATEX GLOVES. PREGNANT WOMEN OR WOMEN WHO MAY BE PREGNANT SHOULD NOT HANDLE SWINEMATE®. WOMEN OF CHILDBEARING AGE SHOULD EXERCISE EXTREME CAUTION WHEN HANDLING THIS PRODUCT. SwineMate® is readily absorbed through the skin and could lead to a disruption of the menstrual cycle or prolongation of pregnancy. People who should not handle this product include those with thrombophlebitis, thromboembolic disorders, or with a history of these events, cerebral-vascular or coronary-artery disease, suspected estrogen-dependent neoplasia, benign or malignant tumors which developed during the use of oral contraceptives or other estrogen containing products, liver dysfunction or disease, and women with known or suspected carcinoma of the breast or undiagnosed vaginal bleeding. Accidental spillage on the skin should be washed off immediately with soap and water. Keep out of the reach of children. For complete safety information, refer to the product label.